Characteristics of 26 patients with type 3 Gaucher disease: A descriptive analysis from the Gaucher Outcome Survey.

about

Characteristics of 26 patients with type 3 Gaucher disease: A descriptive analysis from the Gaucher Outcome Survey.

Item

http://www.wikidata.org/entity/Q47377712

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Characteristics of 26 patients ...... om the Gaucher Outcome Survey.

@en

Characteristics of 26 patients ...... om the Gaucher Outcome Survey.

@nl

type

Item

label

Characteristics of 26 patients ...... om the Gaucher Outcome Survey.

@en

Characteristics of 26 patients ...... om the Gaucher Outcome Survey.

@nl

prefLabel

Characteristics of 26 patients ...... om the Gaucher Outcome Survey.

@en

Characteristics of 26 patients ...... om the Gaucher Outcome Survey.

@nl

P1476

Characteristics of 26 patients ...... om the Gaucher Outcome Survey.

@en

P2093

Ari Zimran

http://www.w3.org/2001/XMLSchema#string

GOS Study group

http://www.w3.org/2001/XMLSchema#string

Ida Vanessa D Schwartz

http://www.w3.org/2001/XMLSchema#string

Lydie Renault

http://www.w3.org/2001/XMLSchema#string

Patrick Deegan

http://www.w3.org/2001/XMLSchema#string

Priya S Kishnani

http://www.w3.org/2001/XMLSchema#string

Zoya Panahloo

http://www.w3.org/2001/XMLSchema#string

Özlem Göker-Alpan

http://www.w3.org/2001/XMLSchema#string

P2860

Randomized, controlled trial of miglustat in Gaucher's disease type 3.

The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease.

Revised recommendations for the management of Gaucher disease in children.

Long-term clinical outcomes in type 1 Gaucher disease following 10 years of imiglucerase treatment

Persistent immune alterations and comorbidities in splenectomized patients with Gaucher disease.

Long-term hematological, visceral, and growth outcomes in children with Gaucher disease type 3 treated with imiglucerase in the International Collaborative Gaucher Group Gaucher Registry.

Impact of imiglucerase supply shortage on clinical and laboratory parameters in Norrbottnian patients with Gaucher disease type 3

Ambroxol chaperone therapy for neuronopathic Gaucher disease: A pilot study.

Gaucher disease among Chinese patients: review on genotype/phenotype correlation from 29 patients and identification of novel and rare alleles.

Dose-response relationships for enzyme replacement therapy with imiglucerase/alglucerase in patients with Gaucher disease type 1.

P304

73-79

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.YMGMR.2017.10.011

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29326879

http://www.w3.org/2001/XMLSchema#string

P932

5758841

http://www.w3.org/2001/XMLSchema#string